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Parasitic infections, caused by intestinal helminths 
and protozoan parasites, are among the most preva-
lent infections in humans in developing coun-
tries. In developed countries, protozoan parasites 
more commonly cause gastrointestinal infections 
compared to helminths. Intestinal parasites cause 
a significant morbidity and mortality in endemic 
countries.
Helminths are worms with many cells. Nematodes 
(roundworms), cestodes (tapeworms), and trema-
todes (flatworms) are among the most common 
helminths that inhabit the human gut. Usually, 
helminths cannot multiply in the human body. 
Protozoan parasites that have only one cell can 
multiply inside the human body. There are four spe-
cies of intestinal helminthic parasites, also known 
as geohelminths and soil-transmitted helminths: 
Ascaris lumbricoides (roundworm), Trichiuris trichiu-
ria (whipworm), Ancylostoma duodenale, and Neca-
tor americanicus (hookworms). These infections are 
most prevalent in tropical and subtropical regions 
of the developing world where adequate water and 
sanitation facilities are lacking (1,2). Recent esti-
mates suggest that A. lumbricoides can infect over 
a billion, T. trichiura 795 million, and  hookworms 
740 million people (3). Other species of intesti-
nal helminths are not widely prevalent. Intestinal 
helminths rarely cause death. Instead, the burden 
of disease is related to less mortality than to the 
chronic and insidious effects on health and nutri-
tional status of the host (4,5). In addition to their 
health effects, intestinal helminth infections also 
impair physical and mental growth of children, 
thwart educational achievement, and hinder eco-
nomic development (6,7).
The most common intestinal protozoan parasites 
are: Giardia intestinalis, Entamoeba histolytica, Cy-
clospora cayetanenensis, and Cryptosporidium spp.   
The diseases caused by these intestinal protozoan 
parasites are known as giardiasis, amoebiasis, cy-
closporiasis, and cryptosporidiosis respectively, and 
they are associated with diarrhoea (8). G. intestinalis 
is the most prevalent parasitic cause of diarrhoea 
in the developed world, and this infection is also 
very common in developing countries. Amoebiasis 
is the third leading cause of death from parasitic 
diseases worldwide, with its greatest impact on the 
people of developing countries. The World Health 
Organization (WHO) estimates that approximately 
50 million people worldwide suffer from invasive 
amoebic infection each year, resulting in 40-100 
thousand deaths annually (9,10). Cryptosporidio-
sis is becoming most prevalent in both developed 
and developing countries among patients with 
AIDS and among children aged less than five years. 
Several outbreaks of diarrhoeal disease caused by 
C. cayetanensis have been reported during the last 
decade (11). Spread of these protozoan parasites in 
developing countries mostly occurs through faecal 
contamination as a result of poor sewage and poor 
quality of water. Food and water-borne outbreaks 
of these protozoan parasites have occurred, and the 
infectious cyst form of the parasites is relatively re-
sistant to chlorine (12). Other species of protozoan 
parasites can also be found in the human gut, but 
they are not pathogenic, except Microsporidia sp.
In an article published in this issue of the Journal, 
Jacobsen et al. looked at the prevalence of intes-
tinal parasites in young Quichua children in the 
highland or rural Ecuador (13). They have found 
a high prevalence of intestinal parasites, especially 
the intestinal protozoan parasites. They have used 
the traditional microscopic technique to diagnose 
intestinal parasitic infections. In total, 203 stool 
samples were examined from children aged 12-
60 months  and found  that 85.7%  of them had at 
least on parasite. The overall prevalence of in-
testinal protozoan parasites were: E. histolytica/E. 
dispar 57.1%, Escherichia coli 34.0%, G. intestinalis 
21.1%, C. parvum 8.9%, and C. mesnili 1.7%, while 
the prevalence of intestinal helminthic parasites in 
this study were: A. lumbricoides 35.5%, T. trichiura 
0.5 %, H. diminuta 1.0%, and S. stercoralis 0.7%. A 
recent study in Nicaragua in asymptomatic indi-
viduals found that 12.1% (58/480) were positive 
for E. histolytica/E. dispar by microscopy, but E. his-
tolytica and E. disapr were positive by polymerase 
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samples respectively among the microscopic posi-
tive samples (Unpublished data). This study proves 
again that the diagnosis of E. histolytica/E. dispar is 
neither sensitive nor specific when it is done by mi-
croscopy. To understand the real prevalence of E. 
histolytica-associated infection, a molecular method 
must be used for its diagnosis.
Over the last several years, we have seen new ap-
proaches to the diagnosis, treatment, and preven-
tion of intestinal protozoan parasites. However, 
the diagnosis and treatment of intestinal helminth 
infections have not been changed much, and the 
traditional microscopic method can be used for 
their diagnosis. Antigen-detection tests are now 
commercially available for the diagnosis of all 
three major intestinal protozoan parasites. Diagno-
sis of E. histolytica cannot be done any longer by 
microscopy, since this parasite is morphologically 
similar to the non-pathogenic parasite E. dispar. 
E. histolytica-specific antigen-detection test is now 
commercially available from TechLab, Blacksburg, 
Virginia, for the detection of E. histolytica  antigen 
in stool specimens (14,15). In several studies, this 
E. histolytica-specific antigen-detection test has 
been used for the specific detection of E. histolytica 
(16,17). These studies have found that this antigen-
detection test is sensitive and specific for the de-
tection of E. histolytica. In a study in Bangladesh, 
E. histolytica-specific antigen-detection test identi-
fied E. histolytica in 50 of 1,164 asymptomatic pre-
school children aged 2-5 years (18). In a study in 
Nicaragua among patients with diarrhoea, where 
E. histolytica-specific test has been used, found that 
the prevalence of E. histolytica was 0.5% (19). In a 
study conducted in a cohort of Bangladeshi chil-
dren found that the prevalence of E. histolytica in 
diarrhoeal stool samples was 8.0% (20). No studies 
that have been carried till date using E. histolytica-
specific diagnostic test reported the prevalence of 
E. histolytica more than 10%. In addition to the an-
tigen-detection test, several PCR-based tests specific 
for E. histolytica have been developed and used for 
specific detection of E. histolytica (21,22). Rapid di-
agnostic test for the detection of E. histolytica anti-
gen in stool specimens has also been reported (23). 
Diagnosis of giardiasis is best accomplished by de-
tection of Giardia antigen in stool, since the classic 
microscopic examination is less sensitive and spe-
cific. A recent comparison of nine different 
antigen-detection tests demonstrated that all had 
high sensitivity and specificity, except one (24). 
Giardia-specific antigen-detection tests are now 
also commercially available from several diagnostic 
companies, and their performance is quite good, 
except a few. In addition to antigen-detection 
tests, PCR-based test for the detection of G. intesti-
nalis has also been reported (25). The population 
genetics of Giardia are complex. However, a recent 
genetic linkage study has confirmed the distinct 
grouping of Giardia in two major types (26). These 
two main genotypes/assemblages of G. intestinals 
are commonly known as: assemblage A and assem-
blage B of G. intestinalis. Differentiation of these 
two assemblages of G. intestinalis can only be done 
by PCR-based tests. Findings of the largest case-con-
trol study conducted to date on the relationship be-
tween genotypes of G. intestinalis and symptoms of 
patients have been published (27). This study has 
shown that the Giardia assemblage A infection is 
associated with diarrhoea. In contrast, Giardia 
assemblage B infection is significantly associated 
with  asymptomatic  Giardia-associated  infection, 
which was found to occur at a significantly higher 
rate (18.0%) as detected by the antigen-detection 
test (27). The PCR-based approach allowed resolu-
tion of infection to the genotype level and brought 
some clarity to the findings of asymptomatic giar-
diasis. Similar large-scale case-control studies need 
to be carried out in other continents to understand 
more on the association of Giardia assemblages 
with diarrhoea/dysentery.
Diagnosis of cryptosporidiosis is also best accom-
plished by detection of Cryptosporidium spp. anti-
gen in stool samples, since classic microscopic ex-
amination is less sensitive, and modified acid-fast 
staining is required. Cryptosporidium spp.-specific 
antigen-detection test has been used in several 
studies and has been found to be sensitive and spe-
cific compared to classic microscopic examination 
and PCR-based test (28,29). There are two main 
species of Cryptosporidium that infect humans: C. 
hominis (genotype I) and C. parvum (genotype II). 
The PCR-based test is required for differentiation 
of these two species of Cryptosporidium spp. (30). 
Both C. hominis and C. parvum have been found 
in humans. There are a few other species of Cryptos-
poridium that also can be found in humans (31-33). 
Rapid diagnostic tests for the detection of G. lamblia 
and Cryptosporidium spp. have also been reported 
(34,35). Multiplex PCR-based test for the detec-
tion of E. histolytica, G. intestinalis, and Cryptosporid-
ium spp. has already been reported, and the deve-
lopment of multiplex antigen-detection test for these 
three  common  and  pathogenic  intestinal  proto-
zoan parasites is underway at TechLab, Blacksburg, 
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2007). These modern antigen-detection tests and 
PCR-based tests need to be used for understanding 
the actual prevalence and epidemiology of these 
protozoan parasites.
Soil-transmitted helminth infections are invariably 
more prevalent in the poorest sections of the popu-
lations in endemic areas of developing countries. 
The goal is to reduce morbidity from soil-transmit-
ted helminth infections to such levels that these in-
fections are no longer of public-health importance. 
An additional goal is to improve the developmental, 
functional and intellectual capacity of affected chil-
dren (37). Highly-effective, safe single-dose drugs, 
such as albendazole, now available, can be dis-
pensed through healthcare services, school health 
programmes, and community interventions direct-
ed at vulnerable groups (38). As these infections are 
endemic in poor communities, more permanent 
control will only be feasible where chemotherapy 
is supplemented by improved water supplies and 
sanitation, strengthened by sanitation education. 
In the long term, this type of permanent transmis-
sion control will only be possible with improved 
living conditions through economic development.   
Intestinal protozoa multiply rapidly in their hosts, 
and as there is a lack of effective vaccines, chemo-
therapy has been the only practised way to treat 
individuals and reduce transmission. The current 
treatment modalities for  intestinal protozoan para-
sites include metronidazole, iodoquinol, diloxanide 
furoate, paromomycin, chloroquine, and trimeth-
oprim-sulphamethoxazole (39). Nitazoxanide, a 
broad-spectrum anti-parasitic agent, was reported 
to be better than placebo for the treatment of cryp-
tosporidiosis in a double-blind study performed in 
Mexico (40). Genomes of these three important 
protozoan parasites  have already been published 
(41-43), and  studies  are underway to understand 
protective immunity to these protozoan parasites 
to develop vaccines for them.
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